Wall Street closes at a record for the first time since end of January
Investing.com - Guggenheim reiterated a Buy rating on Madison Square Garden Sports Corp. (NYSE:MSGS) following the company’s announcement of a potential spin-off transaction. The stock has surged 49.19% over the past six months and is currently trading at $342.14, well above its previous 52-week high of $299.01, according to InvestingPro data.
The company said Wednesday that its Board of Directors unanimously approved a plan to explore separating the Knicks and Rangers into two distinct public companies. The transaction is expected to be structured as a tax-free separation to all company shareholders.
Madison Square Garden Sports said the transaction would allow investors to evaluate each asset more clearly while providing both companies with enhanced strategic and financial flexibility. Guggenheim noted that when a MSG or Dolan company initiates such a process, follow-through action typically occurs. Despite the positive market reaction, InvestingPro analysis indicates MSGS is significantly overvalued compared to its Fair Value, with the company not profitable over the last twelve months.
Third-party valuations place the New York Rangers at $3.65 billion according to Sportico and $4.0 billion according to Forbes. The New York Knicks is valued at $9.85 billion by Sportico, $9.75 billion by Forbes, and $10.1 billion by CNBC.
Based on these third-party valuations, Guggenheim said Madison Square Garden Sports shares should trade at $540 to $570 or more per share, representing an 84% to 94% premium to the prior day’s close. The firm noted that third-party valuations have historically been conservative relative to actual transaction prices. With MSGS’s current market cap of $8.24 billion, these team valuations suggest significant potential upside. For deeper insights into MSGS’s financial health and comprehensive analysis, check out the Pro Research Report available on InvestingPro, which covers this and 1,400+ other US equities.
In other recent news, Madison Square Garden Sports Corp. reported its earnings for the second quarter of fiscal year 2026, with an earnings per share (EPS) of $0.34, missing the forecasted $0.52 by 34.62%. However, the company exceeded revenue expectations, reporting $403.4 million, which surpassed estimates by 2.14%. This revenue growth was partly due to four additional games at The Garden compared to the same period last year. In related developments, Madison Square Garden Sports announced plans to explore a potential spin-off, separating its New York Knicks and New York Rangers businesses into two distinct publicly traded companies. This proposed tax-free spin-off would distribute 100% of the common stock in the new company to current shareholders on a pro-rata basis. The move aims to provide clearer evaluation of each franchise’s assets and future prospects. Additionally, Guggenheim raised its price target for Madison Square Garden Sports to $355 from $314, maintaining a Buy rating on the stock. The price target increase followed the company’s fiscal second-quarter results, reflecting positive sentiment from the firm.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.